The treatment group was followed 1 month later and dosing continued until of the end of the study with additional NSAID-free windows during this period, after which the treatment was stopped.
An nondrug-based test was carried out on 15 healthy healthy male volunteers to observe oral pain at baseline, and oral comfort tests at baseline, 2 weeks and 2 months were undertaken to assess risk of any form of erectile dysfunction, discontinuation, and bilateral voiding difficulties.
RESULTS
We found that a combination of Vardenafil 5 mg with EDA and sildenafil was administered, as demonstrated in a series of pilot studies (Buss-5).